Translational Development Acquisition Corp. Ordinary Shares (TDAC) Stock Analysis

Translational Development Acquisition Corp. Ordinary Shares (TDAC) is a publicly traded company in the FINANCIAL SERVICES sector. It trades at $10.75, carries a market capitalization of $235.51M, a price-to-earnings ratio of 38.39. This page summarizes the public market data, fundamentals, and frequently asked questions for TDAC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: FINANCIAL SERVICES - SHELL COMPANIES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Translational Development Acquisition Corp. Ordinary Shares currently has a Bullish sentiment score of 0.26.

About Translational Development Acquisition Corp. Ordinary Shares

Translational Development Acquisition Corp. (TDAC) is a special purpose acquisition company (SPAC) based in New York, focused on identifying and partnering with innovative companies in the life sciences sector. The firm aims to leverage its team’s expertise to accelerate growth and deliver transformative healthcare solutions by facilitating mergers and acquisitions. With a strategic vision to capitalize on emerging markets within biotechnology and pharmaceuticals, TDAC is well-positioned to c...

GNG Research Analysis

GNG Research scores Translational Development Acquisition Corp. Ordinary Shares (TDAC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TDAC.

Frequently Asked Questions

Does TDAC pay dividends?

Translational Development Acquisition Corp. Ordinary Shares (TDAC) does not currently pay a regular dividend.

What is TDAC's P/E ratio?

Translational Development Acquisition Corp. Ordinary Shares has a price-to-earnings (P/E) ratio of 38.39.

What is TDAC's market cap?

Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a market capitalization of $235.51M with a current stock price of $10.75.